Health on MSN10d
What To Know About Diabetic Macular Edema (DME)
Medically reviewed by Danielle Weiss, MD Diabetic macular edema (DME) is a leading cause of vision loss in people with ...
The Print on MSN2d
Silent threat of diabetic retinopathy: Eye doctors bat for advanced treatments to be part of AB-PMJAY
Diabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections ...
UNITY Biotechnology Shares Drop 33% After Phase 2b Trial Data on UBX1325 in Diabetic Macular Edema
Complete 36-week results from the ASPIRE study involving 52 patients are expected in the second quarter of 2025.
Clinical Trials Arena on MSN13d
Unity reports topline outcomes from trial of diabetic macular oedema therapy
Unity Biotechnology has reported outcomes from its randomised Phase IIb ASPIRE study of intravitreal UBX1325 for diabetic ...
Ophthalmology Times13d
Unity Biotechnology releases topline results from phase 2b ASPIRE trial of UBX1325 in patients with diabetic macular edema
UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving ...
Ophthalmology Times11d
Electroretinography reveals limited duration of dexamethasone implant efficacy in DME
The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...
Yahoo Finance11d
Docquity and Novartis Partner to Tackle Retinal Health Challenges in Malaysia
Harnessing Docquity's insights-driven, omnichannel commercial capabilities under its Awareness to Advocacy (A2A) Program, Novartis enhances retinal health education for thousands of ...